TG Therapeutics, Inc. Announces Poster Presentations For TGR-1202 At The Upcoming 55th American Society of Hematology Meeting

NEW YORK, Dec. 5, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that the following abstracts for TGR-1202, the Company's PI3K delta inhibitor, have been selected for poster presentation at the upcoming 55th Annual Meeting of the American Society of Hematology (ASH), to be held December 7 -10, 2013, at the Ernest N. Morial Convention Center, New Orleans, LA:

Help employers find you! Check out all the jobs and post your resume.